Xenometrix Overview

  • Year Founded
  • 1991

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Xenometrix General Information

Description

Operator of a biotechnology company intended to help the pharmaceutical industry improve the effectiveness of drug discovery and development through lead compound optimization. The company specializes in proprietary gene response profiling technology and genotoxicity technology, enabling pharmaceutical, chemical and biotechnology industries to accelerate the selection of promising drug and chemical leads.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 2425 North 55th Street
  • Boulder, CO 80301-5700
  • United States
Primary Industry
Discovery Tools (Healthcare)
Vertical(s)
Corporate Office
  • 2425 North 55th Street
  • Boulder, CO 80301-5700
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Xenometrix Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Xenometrix‘s full profile, request access.

Request a free trial

Xenometrix Patents

Xenometrix Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
ES-2111289-T3 Diagnostic methods and kits that use stress promoters in mammals to determine the toxicity of a compound. Inactive 21-Jan-1993
DE-69406772-D1 Method and diagnostic kits using mammal stress promotors for determining the toxicity of a connection Inactive 21-Jan-1993
DE-69406772-T2 Method and diagnostic kits using mammal stress promotors for determining the toxicity of a connection Inactive 21-Jan-1993
DE-69406772-T3 Method and diagnostic kits using sugar stresspromotors to determine the toxicity of a compound Inactive 21-Jan-1993
ES-2111289-T5 Methods and diagnosis kits that use stress promoters in mammals to determine the toxicity of a compound. Inactive 21-Jan-1993 C12Q1/6897
To view Xenometrix’s complete patent history, request access »

Xenometrix FAQs

  • When was Xenometrix founded?

    Xenometrix was founded in 1991.

  • Where is Xenometrix headquartered?

    Xenometrix is headquartered in Boulder, CO.

  • What industry is Xenometrix in?

    Xenometrix’s primary industry is Discovery Tools (Healthcare).

  • Is Xenometrix a private or public company?

    Xenometrix is a Private company.

  • What is the current valuation of Xenometrix?

    The current valuation of Xenometrix is .

  • What is Xenometrix’s current revenue?

    The current revenue for Xenometrix is .

  • When was Xenometrix acquired?

    Xenometrix was acquired on 09-May-2001.

  • Who acquired Xenometrix?

    Xenometrix was acquired by Discovery Partners International.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process